Your browser doesn't support javascript.
loading
A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1-Infected Patients.
Fehér, Csaba; Plana, Montserrat; Crespo Guardo, Alberto; Climent, Nuria; Leal, Lorna; Ugarte, Ainoa; Fernández, Irene; Etcheverry, María F; Gatell, Josep M; Sánchez-Palomino, Sonsoles; García, Felipe; Aloy, Patrick.
Afiliación
  • Fehér C; Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain.
  • Plana M; Infectious Diseases Department, Hospital Clinic of Barcelona-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Crespo Guardo A; Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Climent N; Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Leal L; Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Ugarte A; Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Fernández I; Infectious Diseases Department, Hospital Clinic of Barcelona-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Etcheverry MF; Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS)-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Gatell JM; Infectious Diseases Department, Hospital Clinic of Barcelona-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Sánchez-Palomino S; Infectious Diseases Department, Hospital Clinic of Barcelona-HIVACAT, University of Barcelona, Barcelona, Spain.
  • García F; Infectious Diseases Department, Hospital Clinic of Barcelona-HIVACAT, University of Barcelona, Barcelona, Spain.
  • Aloy P; University of Barcelona, ViiV Healthcare Barcelona, Barcelona, Spain; and.
J Acquir Immune Defic Syndr ; 83(5): 479-485, 2020 04 15.
Article en En | MEDLINE | ID: mdl-31904703
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA / Antirretrovirales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Vacunas contra el SIDA / Antirretrovirales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2020 Tipo del documento: Article País de afiliación: España